過去的研究指出3,3'-二吲哚甲烷具有抗癌的效果。本實驗分析3,3'-二吲哚甲烷在不同HER2及p53蛋白質含量的卵巢癌細胞之抗細胞增生效果。這個研究發現，3,3'-二吲哚甲烷可能透過延滯細胞週期造成抑制卵巢癌細胞的生長。3,3'-二吲哚甲烷透過改變Cyclin dependent kinases inhibitors (p21, and/or p27)的蛋白質含量，抑制了MDAH-2774、SKOV-3及TOV-21G的增生。總結，這研究發現3,3'-二吲哚甲烷可能具有發展成化學預防和治療卵巢癌劑的能力。

3,3'-Diindolylmethane (DIM) has been reported to exhibit anti-tumor activities. Here I had examined the anti-proliferating effects of 3,3'-diindolylmethane on different HER2 and p53 protein levels of ovarian cancer cell lines. This study found that 3,3'-diindolylmethane inhibit ovarian cancer cells growth may via cycle arrest. Inhibition of MDAH-2774, SKOV-3 and TOV-21G ovarian cells proliferation by DIM depends on changes in Cyclin dependent kinases inhibitors (p21, and/or p27). In summary, these findings suggest that DIM may be a potential chemopreventive and therapeutic agent for ovarian cancer.

第一章 緒論……………………………………………………………1
第一節 卵巢癌細胞簡介………………………………………………1
第二節 3,3'-二吲哚甲烷簡介…………………………………………2
第三節 細胞週期的概論………………………………………………5
第四節 研究動機與目的 ……………………………………………15

第二章 材料與方法……………………………………………16
第一節 實驗材料………………………………………………………16
第二節 實驗方法………………………………………………………18

第三章 結果……………………………………………………21
第一節 實驗結果……………………………………………………21
第二節 實驗圖表……………………………………………………24

第四章 結論與討論……………………………………………33
第五章 參考文獻…………………………………………………36
附錄 43

圖目錄
圖一3,3'-二吲哚甲烷對卵巢癌細胞SKOV-3、TOV-21G、MDAH-2774 的外觀形態上之影響………………………………………………..…24
圖二3,3'-二吲哚甲烷對卵巢癌細胞SKOV-3、TOV-21G、MDAH-2774 之細胞生長影響……………………………………..…………………27
圖三 3,3'-二吲哚甲烷對卵巢癌細胞SKOV-3、TOV-21G、MDAH-2774之pAKT及AKT蛋白質的影響…………………………….……..….28
圖四 3,3'-二吲哚甲烷對卵巢癌細胞SKOV-3、TOV-21G、MDAH-2774的CDKI蛋白質影響…………………………………….……………..29
圖五 3,3'-二吲哚甲烷對卵巢癌細胞SKOV-3、TOV-21G、MDAH-2774的G1期之Cyclin及CDK蛋白質影響…….………………………….30

Ali S, Banerjee S, Ahmad A, El-Rayes BF, Philip PA, Sarkar FH (2008) .Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer. Mol Cancer Ther 7: 1708-19.

Bukholm IR, Husdal A, Nesland JM, Langerod A, Bukholm G (2003) .Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time. Breast Cancer Res Treat 80: 199-206.

Carmeliet P, Jain RK (2000) .Angiogenesis in cancer and other diseases. Nature 407: 249-57.

Chae HD, Yun J, Bang YJ, Shin DY (2004). Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions. Oncogene 23: 4084-8.

Chang X, Firestone GL, Bjeldanes LF (2006). Inhibition of growth factor-induced Ras signaling in vascular endothelial cells and angiogenesis by 3,3'-diindolylmethane. Carcinogenesis 27: 541-50.

Chang X, Tou JC, Hong C, Kim HA, Riby JE, Firestone GL, Bjeldanes LF. (2005). 3,3'-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis 26: 771-8.

Chen I, McDougal A, Wang F, Safe S (1998). Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19: 1631-9.

Choi HJ, Lim do Y, Park JH (2009). Induction of G1 and G2/M cell cycle arrests by the dietary compound 3,3'-diindolylmethane in HT-29 human colon cancer cells. BMC Gastroenterol 9: 39.

Chung DC (2004). Cyclin D1 in human neuroendocrine: tumorigenesis. Ann N Y Acad Sci 1014: 209-17.

Cram EJ, Liu BD, Bjeldanes LF, Firestone GL (2001). Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter. J Biol Chem 276: 22332-40.

Dong L, Xia S, Gao F, Zhang D, Chen J, Zhang J（2010）3,3'-Diindolylmethane attenuates experimental arthritis and osteoclastogenesis. Biochem Pharmacol 79: 715-21.

Donovan J, Slingerland J (2000). Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer. Breast Cancer Res 2: 116-24.

Egloff AM, Vella LA, Finn OJ (2006). Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer. Cancer Res 66: 6-9.

Elledge SJ (1996). Cell cycle checkpoints: preventing an identity crisis. Science 274: 1664-72.

Firestone GL, Bjeldanes LF (2003). Indole-3-carbinol and 3-3'-diindolylmethane antiproliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions. J Nutr 133: 2448S-2455S.

Fotedar R, Fitzgerald P, Rousselle T, Cannella D, Dorée M, Messier H, Fotedar A. (1996). p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity. Oncogene 12: 2155-64.

Garikapaty VP, Ashok BT, Tadi K, Mittelman A, Tiwari RK (2006). 3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochem Biophys Res Commun 340: 718-25.

Ge X, Fares FA, Yannai S (1999). Induction of apoptosis in MCF-7 cells by indole-3-carbinol is independent of p53 and Bax. Anticancer Res 19: 3199-203.

Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, Rideout WM, Bronson RT, Gardner H, Sicinski P. (2003). Cyclin E ablation in the mouse. Cell 114: 431-43.

Hong C, Firestone GL, Bjeldanes LF (2002a). Bcl-2 family-mediated apoptotic effects of 3,3'-diindolylmethane (DIM) in human breast cancer cells. Biochem Pharmacol 63: 1085-97.

Hong C, Kim HA, Firestone GL, Bjeldanes LF (2002b). 3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 23: 1297-305.

Ito M (2000). Factors controlling cyclin B expression. Plant Mol Biol 43: 677-90.

Jones SM, Klinghoffer R, Prestwich GD, Toker A, Kazlauskas A (1999). PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1. Curr Biol 9: 512-21.

Kim EJ, Park SY, Shin HK, Kwon DY, Surh YJ, Park JH (2007). Activation of caspase-8 contributes to 3,3'-diindolylmethane-induced apoptosis in colon cancer cells. J Nutr 137: 31-6.

Kong D, Li Y, Wang Z, Banerjee S, Sarkar FH (2007). Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Res 67: 3310-9.

Kumar S, Bryant CS, Chamala S, Qazi A, Seward S, Pal J, Steffes CP, Weaver DW, Morris R, Malone JM, Shammas MA, Prasad M, Batchu RB. (2009). Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells. Mol Cancer 8: 26.

Lindqvist A, Rodriguez-Bravo V, Medema RH (2009). The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J Cell Biol 185: 193-202.

Maddika S, Ande SR, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, Eshraghi M, Manda KD, Wiechec E, Los M. (2007). Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat 10: 13-29.

Morgan DO (1997). Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 13: 261-91.

Murray AW (2004). Recycling the cell cycle: cyclins revisited. Cell 116: 221-34.

Pellegata NS, Antoniono RJ, Redpath JL, Stanbridge EJ (1996). DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci U S A 93: 15209-14.

Rahimi M, Huang KL, Tang CK （2010）3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants. Cancer Lett 295(1):59-68.

Rahman KW, Sarkar FH (2005). Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells. Cancer Res 65: 364-71.

Saville MK, Watson RJ (1998). The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties. Oncogene 17: 2679-89.

Sherr CJ (1994). G1 phase progression: cycling on cue. Cell 79: 551-5.

Sherr CJ (1996). Cancer cell cycles. Science 274: 1672-7.

Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL. (2002). PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8: 1145-52.

Sui L, Dong Y, Ohno M, Sugimoto K, Tai Y, Hando T, Tokuda M. (2001). Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors. Gynecol Oncol 83: 56-63.

Vanderlaag K, Samudio I, Burghardt R, Barhoumi R, Safe S (2006). Inhibition of breast cancer cell growth and induction of cell death by 1,1-bis(3'-indolyl)methane (DIM) and 5,5'-dibromoDIM. Cancer Lett 236: 198-212.

Vivar OI, Lin CL, Firestone GL, Bjeldanes LF (2009). 3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status. Biochem Pharmacol 78: 469-76.

Wang Z, Yu BW, Rahman KM, Ahmad F, Sarkar FH (2008). Induction of growth arrest and apoptosis in human breast cancer cells by 3,3-diindolylmethane is associated with induction and nuclear localization of p27kip. Mol Cancer Ther 7: 341-9.

Weng JR, Tsai CH, Kulp SK, Chen CS (2008). Indole-3-carbinol as a chemopreventive and anti-cancer agent. Cancer Lett 262: 153-63.

Yang R, Muller C, Huynh V, Fung YK, Yee AS, Koeffler HP (1999). Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins. Mol Cell Biol 19: 2400-7.

Zhang M, Yang H (2009). Negative growth regulators of the cell cycle machinery and cancer. Pathophysiology 16: 305-9.

Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC (2001a). Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3: 245-52.

Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC (2001b). HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 3: 973-82.

Ziebold U, Bartsch O, Marais R, Ferrari S, Klempnauer KH (1997). Phosphorylation and activation of B-Myb by cyclin A-Cdk2. Curr Biol 7: 253-60.

臺灣十大死因與防治 : 遠離疾病的身心健康手冊，陳建宇主編，臺北市 : 聯經出版事業公司，1999 

Lewis J. Kleinsmith, PRINCIPLES of Cancer Biology, PEARSON BENJAMIN CUMMINGS, Pearson International Edition 

行政院衛生署，死亡統計表 2008

3,3'-二吲哚甲烷抑制神經膠原致癌基因表現和轉移特性之研究，施伊珊，2008淡江大學碩士論文